Latest News & Updates
Breaking News
39 minutes ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Generic semaglutide clears Health Canada for second time
OneSource Specialty Pharma secures Health Canada approval for generic semaglutide, becoming the second generic entrant in Canada's GLP-1 injectable market.
Pharma Now Editorial Team
India raises rare disease funding ceiling to Rs 50 lakh per patient
India revises its rare disease framework, raising patient funding to Rs 50 lakh and prioritising genetic screening and indigenous therapy development.
Pharma Now Editorial Team
IDEAYA's RTOR pathway choice sets a sequencing template for oncology NDAs
IDEAYA Biosciences enters RTOR for darovasertib NDA, offering a live sequencing template for oncology regulatory teams targeting accelerated approval.
Pharma Now Editorial Team
UAE pharma localization gets a regulatory partnership push
EDE and Arcera formalise an MoU targeting UAE pharmaceutical manufacturing capacity, with downstream implications for GMP standards and market access conditions.
Pharma Now Editorial Team
